Compare Centrus Energy Corp (LEU) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Centrus Energy Corp vs Stryker Corporation — how do they compare? Centrus Energy Corp trades at $142.44 (market cap $2.91B), while Stryker Corporation trades at $277.33 (market cap $106.24B). The key difference: Stryker Corporation is far larger — about 36.5× Centrus Energy Corp's market cap, and Stryker Corporation pays a 1.27% dividend while Centrus Energy Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Centrus Energy Corp for 29 Days and Stryker Corporation for 21 Days on average.
| LEU | SYK | |
|---|---|---|
Market Cap | $2.91B | $106.24B |
Volume | 903,777 | 2,982,001 |
Sector | Energy | Health |
52-Week High | $436.00 | $388.35 |
52-Week Low | $138.18 | $269.75 |
Typical Hold Time | 29 Days | 21 Days |
Enterprise Value | $2.22B | $117.70B |
Dividend Yield | — | 1.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Centrus Energy (LEU) trades at $142.09, down 3.43% today, with a bearish technical signal from moving averages. The company reported mixed Q2 2026 earnings with an EPS beat but faces declining profitability margins year-over-year. Recent news highlights Centrus' strategic position as the sole US-licensed producer of high-assay low-enriched uranium (HALEU), securing multiple supply contracts amid growing nuclear energy demand.
Outlook: LEU offers exposure to the nuclear fuel supply chain with strong analyst support (46% buy ratings) and a $218.10 consensus price target. Key risks include execution challenges, volatile cash flows, and high valuation multiples (P/E 75.18). The stock's near-term performance hinges on operational execution and contract ramp-up.
Stryker (SYK) trades at $276.97, up 0.57% with mixed technical signals showing bearish moving averages but neutral oscillators. The company maintains strong profitability with 64.98% gross margins and 14.43% net income margin, though recent Q1 2026 earnings missed expectations. Analyst consensus remains strongly bullish with 71% buy ratings and $368.11 price target, representing 33% upside potential. Recent news highlights ongoing legal investigations regarding manufacturing issues that caused an 8.8% stock drop in September 2026.
SYK presents a compelling investment case with robust fundamentals and strong analyst support, though near-term headwinds from legal scrutiny and manufacturing challenges create uncertainty. The stock's current valuation at 28.7 P/E appears reasonable given growth prospects, but investors should monitor Q3 2026 earnings results on October 29 for confirmation of business recovery from recent setbacks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Centrus Energy Corp
Centrus Energy is a leading supplier of nuclear fuel and services for the global power industry. It specializes in supplying low-enriched uranium and developing next-generation fuels for advanced nuclear reactors.
Read more on LEU →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
